Published: February 04, 2010
Tennessee Reproductive Medicine to Offer IntegraMed Attain IVF Program to Fertility Patients
CHATTANOOGA, Tenn. - (BUSINESS WIRE) - IntegraMed
America, Inc. (NASDAQ: INMD), the nation's leading manager of
specialty outpatient healthcare facilities in the emerging,
technology-focused medical niches of fertility and vein care, announced
today that Tennessee Reproductive Medicine will begin offering IntegraMed's
Attain IVF programs, course-of-treatment financing programs that
improve patient success rates with in vitro fertilization (IVF)
fertility treatments.
The Attain IVF programs, pioneered by IntegraMed, consisting of an
Attain IVF Refund Program and an Attain IVF Multi-cycle Program, offer
IVF patients an attractive alternative to better manage the financial
commitment associated with undergoing IVF treatment. For a discounted,
fixed up-front cost, the Attain IVF Refund Program provides patients
with a series of six IVF treatments while refunding of up to 70% of
their fees if their treatments do not result in having a baby, or 100%
if donor egg cycles do not result in having a baby. The Attain IVF
Multi-Cycle Program also offers a discounted, fixed up-front cost for a
series of four IVF treatments.
The Attain IVF programs offer an opportunity for IVF patients to
increase significantly their chances of success by allowing them to stay
in treatment longer. For more information about the Attain IVF Programs
please visit www.attainivf.com.
Tennessee Reproductive Medicine is located at 6031 Shallowford Drive,
Suite 101, in Chattanooga, TN, and is the medical practice of Ringland
(Rink) Murray, MD and Jessica Scotchie, MD. This state-of-the-art
facility offers couples individualized infertility treatment plans in a
caring environment. The facility includes a comprehensive assisted
reproductive technology (ART) laboratory, providing the ability to
undertake highly complex procedures with techniques such as ICSI,
assisted
hatching and embryo
biopsy. For more information please visit www.trmbaby.com.
Dr. Murray commented, "Dr. Scotchie and I are both very pleased that
Tennessee Reproductive Medicine will now be able to offer our patients
the Attain IVF Programs of fertility financing solutions. We are keenly
aware of the physical, emotional and financial commitments on our IVF
patients and we are happy to do anything we can do to help mitigate that
burden."
Dr. Murray, a native of Chattanooga, has had a distinguished career
practicing medicine and possesses strong operational,
project-management, team-building, and leadership skills. After
attending medical school at the University of Tennessee Health Science
Center in Memphis, Dr. Murray completed his residency in Obstetrics and
Gynecology followed by a fellowship in Reproductive Endocrinology and
Infertility at the University of North Carolina at Chapel Hill. Dr.
Murray has received numerous awards from hospital staff, patients and
residents for his dedication to teaching and delivering outstanding,
compassionate and ethical care. Dr. Murray has spent the past few years
with Fertility Associates of Memphis, where he maintained a busy
practice, specializing in endocrine disorders and infertility. For the
past two years, he has been elected into America's Best Doctors.
Dr. Scotchie has also held numerous leadership positions throughout her
career and presented her prior research at international fertility
conferences. Dr. Scotchie attended medical school at the University of
Florida and completed a residency in Obstetrics and Gynecology and a
fellowship in Reproductive Endocrinology and Infertility at the
University of North Carolina at Chapel Hill. Throughout her training,
Dr. Scotchie received numerous awards including being elected into Alpha
Omega Alpha, the medical honor society, teaching awards from the medical
students at the University of North Carolina, a research award for her
resident research project, and the Housestaff Officer Award given to 5
of 700+ residents annually for exceptional and compassionate patient
care.
"Offering the Attain IVF Program at Tennessee Reproductive Medicine
helps to further expand our program's presence in the greater Tennessee
area, an area which we feel affords strong growth opportunities," said
Pamela Schumann, President of the Consumer Services Division of
IntegraMed. "We look forward to providing these value-added options to
patients of Tennessee Reproductive Medicine, and look ahead to working
together with Drs. Murray and Scotchie to achieve great success from
this relationship."
About IntegraMed America, Inc.
IntegraMed America, Inc. manages highly specialized outpatient
facilities in emerging, technology-based, niche medical markets and is
the leading manager of fertility centers and vein clinics in the United
States. IntegraMed supports its provider networks with clinical and
business information systems, marketing and sales, facilities and
operations management, finance and accounting, human resources, legal,
risk management and quality assurance services. IntegraMed also offers
treatment-financing programs for self-pay patients.
IntegraMed's fertility network is the nations largest fertility network,
comprised of 39 contracted centers with over 120 locations in 34 states
and the District of Columbia. Nearly one of every four IVF procedures in
the U.S. is performed in an IntegraMed network fertility practice. The
IntegraMed Vein Clinic network is the leading provider of varicose vein
care services in the US, currently operating 34 centers in 13 states,
principally in the Midwest and Southeast.
For more information about IntegraMed please visit:
Statements contained in this press release that are not based on
historical fact, including statements concerning future results,
performance, expectations and expansion of IntegraMed are
forward-looking statements that may involve a number of risks and
uncertainties. Actual results may differ materially from the
statements made as a result of various factors, including, but not
limited to, the risks associated with IntegraMed's ability to identify,
consummate and finance future growth, including larger-scale
acquisitions; changes in insurance coverage, government laws and
regulations regarding health care or managed care contracting; and other
risks, including those identified in the company's most recent Form 10-K
and in other documents filed by IntegraMed with the U.S. Securities and
Exchange Commission. All information in this press release is as
of February 4, 2010, and IntegraMed undertakes no duty to update this
information.
Investors:
IntegraMed America, Inc.
John W. Hlywak,
Jr., EVP and CFO
914-251-4143
jhlywak@integramed.com
or
Media/Investors:
Jaffoni
& Collins Incorporated
Norberto Aja, David Collins
212-835-8500
inmd@jcir.com
Copyright © 2012, Business Wire, Inc., All rights reserved.
Copyright © 2012, NewsBlaze,
Daily News